Search results: Sage Journals

Free accessReview articleFirst published November, 2011

Certolizumab pegol for the treatment of Crohn’s disease

Stefan Schreiber

Therapeutic Advances in Gastroenterology

Open accessCase reportFirst published 2025

Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report

Paolo Gisondi, Elena Montalto, Tea Curic [...]

Sage Open Medical Case Reports

Available accessResearch articleFirst published February, 2010

Certolizumab Pegol: A TNF-α Antagonist for the Treatment of Moderate-to-Severe Crohn's Disease

Lisa S Smith, Michael Nelson, Christian R Dolder

Annals of Pharmacotherapy

Available accessCase reportFirst published July, 2020

Certolizumab-Induced Paradoxical Psoriatic Alopecia

María Guillermina Ferraresso, María Luz Bollea Garlatti, Lourdes María Perez-Chada [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessReview articleFirst published 2012

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease

Wojciech Blonski, Anna M. Buchner, Gary R. Lichtenstein

Therapeutic Advances in Gastrointestinal Endoscopy

Open accessReview articleFirst published 2024

Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective

Amirhossein Heidari, Yekta Ghane, Nazila Heidari [...]

Sage Open Chronic Disease

Open accessResearch articleFirst published 2022

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Megan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis

William Tillett, Laura C. Coates, Sandeep Kiri [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

Louis Bessette, Boulos Haraoui, Andrew Chow [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published May, 2022

Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers

Ronald B. Vender, Charles W. Lynde

Journal of Cutaneous Medicine and Surgery

Free accessReview articleFirst published November, 2011

Certolizumab pegol for the treatment of Crohn’s disease

Stefan Schreiber

Therapeutic Advances in Gastroenterology

Open accessCase reportFirst published 2025

Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report

Paolo Gisondi, Elena Montalto, Tea Curic [...]

Sage Open Medical Case Reports

Available accessResearch articleFirst published February, 2010

Certolizumab Pegol: A TNF-α Antagonist for the Treatment of Moderate-to-Severe Crohn's Disease

Lisa S Smith, Michael Nelson, Christian R Dolder

Annals of Pharmacotherapy

Available accessCase reportFirst published July, 2020

Certolizumab-Induced Paradoxical Psoriatic Alopecia

María Guillermina Ferraresso, María Luz Bollea Garlatti, Lourdes María Perez-Chada [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessReview articleFirst published 2012

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease

Wojciech Blonski, Anna M. Buchner, Gary R. Lichtenstein

Therapeutic Advances in Gastrointestinal Endoscopy

Open accessReview articleFirst published 2024

Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective

Amirhossein Heidari, Yekta Ghane, Nazila Heidari [...]

Sage Open Chronic Disease

Open accessResearch articleFirst published 2022

Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

Megan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2022

Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis

William Tillett, Laura C. Coates, Sandeep Kiri [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

Louis Bessette, Boulos Haraoui, Andrew Chow [...]

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published May, 2022

Certolizumab Pegol Use in the Treatment of Moderate-to-Severe Psoriasis: Real-World Data From Two Canadian Centers

Ronald B. Vender, Charles W. Lynde

Journal of Cutaneous Medicine and Surgery